Monday, March 17, 2025 | 01:37 AM ISTहिंदी में पढें
Delhivery Ltd
Clarification In The Disclosure Related To Appointment Of Ms. Namita Thapar As An Independent Director Of The Company
03:13 PM, 8th Feb 2025
In continuation to the press release and disclosure submitted under Regulation 30 on Feb 7 2025 we wish to clarify that inadvertently in Ms. Namita Thapars profile it was mentioned that she is the executive Director and CEO of India Business of Emcure Pharmaceuticals Limited. Please note that she is the whole-time director of Emcure Pharmaceuticals Limited and heading its India business.
